Melanoma — Trials · CancerIndex

Clinical trials

Registered studies

3,221 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 605
Recruiting: 316
Ph III recruiting: 30
Growth YoY: +37.2%
Industry share: 33%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (571)

clinicaltrialsPublishedShowing 51–100 of 303 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07803562	Low Dose Dexamethasone for the Prevention of Cytokine Release Syndrome Associated With Tebentafusp(LODEXA)	not yet recruiting	Phase 2	34	University of California, San DiegoOTHER	1	Sep 3, 2026	clinicaltrials
NCT04562129	IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients	active not recruiting	Phase 2	18	H. Lee Moffitt Cancer Center and Research InstituteOTHER	1	Sep 2, 2026